SEARCH

SEARCH BY CITATION

References

  • 1
    Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, Wiener H, Daniel J, von Karsa L, European Commission. European guidelines for quality assurance in cervical cancer screening. 2nd ed. Luxembourg: Office for Official Publications of the European Communities 2008. p. 1291.
  • 2
    Arbyn M, Rebolj M, De Kok IM, Becker N, O’reilly M, Andrae B. Challenges for organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer 2009;45:271421.
  • 3
    Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol 2007;197:3405.
  • 4
    Jordan J, Martin-Hirsch P, Arbyn M, Schenck U, Baldauf JJ, Da Silva D, et al. European guidelines for clinical management of abnormal cervical cytology, part 2. Cytopathology 2009;20:516.
  • 5
    Paraskevaidis E, Kitchener HC, Miller ID, Mann E, Jandial L, Fisher PM. A population-based study of microinvasive disease of the cervix – a colposcopic and cytologic analysis. Gynecol Oncol 1992;45:912.
  • 6
    Arbyn M, Simoens C, Van Oyen H, Foidart JM, Goffin F, Simon P, et al. Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996–2000). Prev Med 2009;48:43843.
  • 7
    Lisfranc J. Memoire sur l’ amputation du col de l’uterus. Gaz Med de Par 1834;2:385
  • 8
    Mathevet P, Chemali E, Roy M, Dargent D. Long term outcome of a randomized study comparing three techniques of conization: cold knife, laser and LEEP. Eur J Obstet Gynecol Reprod Biol 2003;106:2148.
  • 9
    Miler NF, Todd OE. Conization of the cervix. Surg Gynecol Obstet 1983;67:265.
  • 10
    Kirgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial of early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:48998.
  • 11
    Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: a meta-analysis. BMJ 2008;337:a1284.
  • 12
    Crane J, Delaney T, Hutchens D. Transvaginal ultrasonography in the prediction of preterm birth after treatment for cervical intraepithelial neoplasia. Obstet Gynecol 2006;107:3744.
  • 13
    Kristensen J, Langhoff-Ross J, Borlum-Kristensen F. Increased risk of preterm birth in women with cervical conization. Obstet Gynecol 1993;81:10008.
  • 14
    Svare J, Andersen L, Langhoff-Roos J, Jensen ET, Bruun B, Lind I, et al. The relationship between prior cervical conization, cervical microbial colonization and preterm premature rupture of the membranes. Eur J Obstet Gynecol Reprod Biol 1992;47:415.
  • 15
    Leiman G, Harrison NA, Rubin A. Pregnancy following conization of the cervix: complications related to cone size. Am J Obstet Gynecol 1980;136:148.
  • 16
    Buller RE, Jones HW. Pregnancy following cervical conization. Am J Obstet Gynecol 1982;142:50612.
  • 17
    Kuoppala T, Saarikoski S. Pregnancy and delivery after cone biopsy of the cervix. Arch Gynecol 1986;237:14954.
  • 18
    Mccredie MR, Sharples KJ, Paul C, Baranyia J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:42534.
  • 19
    Gentry D, Baggish M, Brady K, Walsh PM, Hungler MS. The effects of loop excision of the transformation zone on cervical length: implications for pregnancy. Am J Obstet Gynecol 2000;3:51620.
  • 20
    International Agency for Research in Cancer (IARC). Cervix cancer screening. Lyon: IARC handbooks of cancer prevention 2005;10:1302.
  • 21
    Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007;197:34655.
  • 22
    Jordan J, Arbyn M, Martin-Hirsch P, Schenck U, Baldauf JJ, Da Silva D, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008;19:34254.
  • 23
    Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J. Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004;96:28093.
  • 24
    Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN. An update of pooled evidence. Gynecol Oncol 2005;99(Suppl. 3):711.
  • 25
    Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J. Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 2006;24(Suppl. 3):S378.
  • 26
    Crane J. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol 2003;102:105862.